Concepts (48)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Ductal, Breast | 2 | 2013 | 86 | 0.460 |
Why?
|
| Receptors, Estrogen | 3 | 2013 | 732 | 0.430 |
Why?
|
| Mucin-4 | 1 | 2012 | 12 | 0.370 |
Why?
|
| Carcinoma, Papillary | 1 | 2013 | 91 | 0.370 |
Why?
|
| Breast Neoplasms | 3 | 2013 | 2598 | 0.350 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 813 | 0.260 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 1316 | 0.220 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 234 | 0.100 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 274 | 0.090 |
Why?
|
| SEER Program | 1 | 2013 | 208 | 0.090 |
Why?
|
| Estrogen Antagonists | 1 | 2012 | 92 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 425 | 0.090 |
Why?
|
| Trastuzumab | 1 | 2012 | 136 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2012 | 237 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 425 | 0.090 |
Why?
|
| Quinazolines | 1 | 2012 | 177 | 0.080 |
Why?
|
| Gene Expression | 2 | 2012 | 1487 | 0.080 |
Why?
|
| Tamoxifen | 1 | 2012 | 348 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2012 | 700 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2012 | 832 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 381 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 999 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 1297 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 993 | 0.070 |
Why?
|
| Survival Rate | 1 | 2013 | 2127 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 566 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3712 | 0.070 |
Why?
|
| Prognosis | 2 | 2013 | 4880 | 0.060 |
Why?
|
| Incidence | 1 | 2013 | 3326 | 0.060 |
Why?
|
| Transcriptome | 1 | 2012 | 1123 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1595 | 0.050 |
Why?
|
| Texas | 1 | 2013 | 3640 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5176 | 0.050 |
Why?
|
| Phenotype | 1 | 2012 | 4479 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2012 | 4679 | 0.040 |
Why?
|
| Female | 3 | 2013 | 70388 | 0.030 |
Why?
|
| Middle Aged | 2 | 2013 | 28438 | 0.030 |
Why?
|
| Mice | 1 | 2012 | 18243 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2013 | 17550 | 0.030 |
Why?
|
| Humans | 3 | 2013 | 130483 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 33862 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 894 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1376 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 1397 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1810 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6809 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 20918 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 31179 | 0.010 |
Why?
|